Pacific Biosciences of California, Inc.
PACB
$1.32
$0.043.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -131.39M | -128.58M | -546.38M | -503.63M | -526.36M |
| Total Depreciation and Amortization | 17.64M | -344.70M | 24.01M | 30.31M | 42.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.18M | 351.43M | 406.71M | 345.22M | 349.96M |
| Change in Net Operating Assets | 7.88M | 10.00M | 4.44M | 5.32M | -15.16M |
| Cash from Operations | -118.05M | -111.84M | -111.21M | -122.79M | -149.55M |
| Capital Expenditure | -5.37M | -4.37M | -2.71M | -3.47M | -2.77M |
| Sale of Property, Plant, and Equipment | 50.00M | 50.00M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.23M | 60.44M | 118.16M | 151.13M | 154.59M |
| Cash from Investing | 120.86M | 106.07M | 115.45M | 147.66M | 151.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -50.20M | -50.20M |
| Issuance of Common Stock | 3.16M | 2.91M | 3.43M | 3.43M | 2.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.16M | 2.91M | 3.43M | -46.77M | -47.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.97M | -2.87M | 7.67M | -21.91M | -45.16M |